Nmd Pharma A/s
Clinical trials sponsored by Nmd Pharma A/s, explained in plain language.
-
New drug trial aims to ease debilitating muscle weakness
Disease control Recruiting nowThis study is testing whether a new medication called NMD670 can help reduce symptoms of myasthenia gravis, a condition that causes muscle weakness. About 84 adults with moderate to severe myasthenia gravis will take either the medication or a placebo pill twice daily for 21 days…
Phase: PHASE2 • Sponsor: NMD Pharma A/S • Aim: Disease control
Last updated Apr 02, 2026 04:41 UTC
-
New drug trial aims to help SMA patients walk farther
Disease control Recruiting nowThis study is testing whether an experimental drug called NMD670 can help adults with spinal muscular atrophy type 3 walk farther and improve muscle strength. Researchers will compare NMD670 against a placebo in 54 participants who can walk at least 50 meters without assistance. …
Phase: PHASE2 • Sponsor: NMD Pharma A/S • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC